177Lu-labeled NY108 SPECT Imaging in Patients

NCT05815394 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: 177Lu-labeled NY108

Sponsor

Affiliated Hospital of Jiangnan University